Skip to main content

Table 1 Patient characteristics

From: Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas

Patient characteristics

Number (n=143)

Median age (range)

54 (30–81)

FIGO stage

 I

82 (57%)

 II

20 (14%)

 III

28 (20%)

 IV

13 (9%)

Histology

 Pure type

134 (94%)

 Mixed type

9 (6%)

  Serous

4 (3%)

  Mucinous

2 (1%)

  Endometrioid

2 (1%)

  Cystadenocarcinofibroma

1 (1%)

Positive peritoneal cytology

66 (46%)

Endometriosis

 Present

74 (52%)

 Absent

69 (48%)

Treatment

 Surgery

143 (100%)

  Lymph node adenectomy

112 (78%)

  Lymph node sampling

5 (3%)

 Chemotherapy

136 (95%)

  Platinum

135 (94%)

  Taxane

122 (85%)

  CPT-11

19 (13%)

Residual tumor present

20 (14%)

  1. FIGO International Federation of Gynecology and Obstetrics, CPT-11 camptothecin-11